Show events:

Search

8th InterAmerican Oncology Conference

'Current Status and Future of Anti-Cancer Therapies'

Date: 17. - 18.10.2019
Time: 09:00 h - 18:00 h

The 8th Conference of IAOC "Current Status and Future of Anti-Cancer Therapies" will be held in Buenos Aires, Argentina in October 17th and 18th, 2018.
An outstanding faculty of speakers from the United States and Europe has committed in this meeting.
The conference agenda will focus on new translational advances in the treatment of cancer as well as provide updates of conventional therapies for a number of the most common tumor types. The meeting objectives are designed to introduce the audience to the latest information on targeted therapies, immunotherapies and emerging treatments in early development.

Medical topics:

Internal Medicine and Haematology and Oncology, Laboratory Medicine, Medicinal Tumour Therapy

Host

InterAmerican Oncology Conferences
Go to address

Venue:

Auditorio UCA - Universidad Católica Argentina, Edificio San José - Salón Juan Pablo II
Av. Alicia M. de Justo 1600
AR 1429 Buenos Aires
Go to map

Booking information

Show hotels near the venue

Recommend this event via e-mail

Host:

InterAmerican Oncology Conferences
n/a
AR n/a Buenos Aires
Phone: N/A
E-mail: maria@oncologyconferences.com.ar

Organiser:

InterAmerican Oncology Conference
n/a
AR 1428 n/a
Phone: n/a
E-mail: secretariat@oncologyconferences.com.ar

Registration:

Online registration: http://www.oncologyconferences.com.ar/registration/
E-mail: secretariat@oncologyconferences.com.ar

Topic Medical topics

Oncology
Innere Medizin und Hämatologie und Onkologie
Venue:

Auditorio UCA - Universidad Católica Argentina, Edificio San José - Salón Juan Pablo II
Av. Alicia M. de Justo 1600
AR 1429 Buenos Aires


View larger map

Rating
Further Information

Frequency: no repetition

Special topics:
NEW ANTICANCER THERAPIES • Promising Novel Agents in Early Clinical Trials: Alex A. Adjei, Rochester, USA • Novel Combination Approaches for Cancer Immunotherapy: TBA • Immune Checkpoint Inhibitors for Melanoma: Antoni Ribas, California, USA • Emerging Checkpoints in Immune and Vascular Signaling Programs in Cancer: Gabriel Rabinovich, Buenos Aires, Argentina • Cancer Biomarkers: Antoni Ribas, California, USA • The Evolution of Cancer Immunotherapy: Ignacio Melero, Pamplona, Spain (*TBC) BREAST CANCER • New Drugs and Treatments in Breast Cancer: Carlos L. Arteaga, Texas, USA • Challenges in the Genomic Selection of Patients: Carlos Barrios, Porto Alegre, Brazil GU CANCER • Novel Therapies in Prostate and Renal Cancer: Charles Drake, Columbia, USA (*TBC) • The Evolution of Targeted Therapy and Checkpoint Inhibitors in Bladder Cancer: Joaquim Bellmunt, Barcelona, Spain GI CANCER • Novel Therapies in Gastric Cancer: Josep Tabernero, Barcelona, Spain • New Treatments for Colorectal Cancer: Josep Tabernero, Barcelona, Spain LUNG CANCER • What’s new in the Management of SCLC: Alex A. Adjei, Rochester, USA • Current Management of NSCLC: Román Pérez Soler, New York, USA • Combination Immunotherapy for Lung Cancer: TBA HEMATOLOGICAL MALIGNANCIES • New Therapies and Treatments in Lymphoma: Stephen Ansell, Rochester, USA • Multiple Myeloma: Kenneth C. Anderson, Boston, USA • Novel Drug Development in Leukemia: Jorge Cortés, Houston, USA

Congress President:
IAOC
secretariat@oncologyconferences.com.ar
http://www.oncologyconferences.com.ar

Tags/key words:
Oncology, Hematology, Urology

HRS.de